Adiponectin (APN)

Overview

Adiponectin is a secreted adipokine and hormone encoded by ADIPOQ that is produced primarily by adipocytes and circulates at high abundance in blood. It is widely recognized as one of the most abundant hormones in the circulation and is closely linked to energy homeostasis, lipid handling, glucose metabolism, and inflammatory regulation. In biomedical research, adiponectin is often studied as a marker and mediator of adipose tissue function, insulin sensitivity, and systemic metabolic health.

At the mechanistic level, adiponectin is associated with signaling pathways involving cAMP, cAMP-dependent protein kinase catalytic subunit, fatty acid oxidation, and broader metabolic adaptation. Its biology is relevant to metabolic disease, aging, and cancer research, where changes in adiponectin levels may reflect altered adipose tissue function or influence tumor cell behavior and redox balance. The protein is also frequently considered alongside other adipokines such as Leptin (LEP) and resistin, and in relation to pathways including PI3K/AKT/HIF-1α, p53/cGAS/STING, and Nrf-2-SLC7A11-GSH in experimental systems.

Recent Publications Summary

Adiponectin research in this period spans metabolic, immune, neurodegenerative, and oncologic contexts, with several studies treating the adipokine or its gene product as a diagnostic readout rather than a therapeutic target. In systemic lupus erythematosus, plasma proteomic profiling of 544 cases and 48,036 controls in the UK Biobank identified 35 high-confidence SLE-associated proteins, and ADIPOQ was retained alongside TRIM21, SOD2, KLK3, and IL-15 in a cost-optimized five-protein panel that preserved substantial diagnostic accuracy (AUC = 0.82) at roughly 87% lower cost than the full protein risk score (AUC = 0.91) 42490652Jul. A parallel biomarker framing appears in Alzheimer's disease, where plasma and CSF adiponectin were measured in 134 participants (90 biomarker-confirmed AD, 44 controls) from a tertiary memory clinic; total and high-molecular-weight (HMW) adiponectin were higher in AD before adjustment but not after correction for age, sex, BMI, and APOE ε4 status, while the HMW/total ratio remained elevated (0.50 vs. 0.43), suggesting that adiponectin isoform distribution rather than absolute concentration may carry the AD-relevant signal 42360686Jun. In ischaemic stroke, elevated adiponectin was examined against 5-year mortality, functional outcome, and recurrence in Chinese patients with first-ever stroke, addressing a persistently debated relationship between this adipocytokine and cardiovascular disease outcomes 41057170Oct.

Endocrine and metabolic profiling studies position adiponectin within broader adipocytokine panels. Across 385 adults stratified into type 2 diabetes mellitus, autoimmune thyroid disease, both conditions, and healthy controls, adiponectin was higher in autoimmune thyroid disease than in T2DM, and in the combined T2DM/AITD group it correlated positively with age and free thyroxine and negatively with BMI, while resistin and visfatin showed distinct patterns (resistin elevated in combined disease and inversely related to TSH in AITD; visfatin lowest in T2DM) 42455070Jul. In pregnancy, adiponectin and leptin were assessed as candidate mediators of the improved maternal cardiovascular function reported after metabolic bariatric surgery 42240794Jun.

Mechanistic work addressed both the upstream regulation of adiponectin expression and its downstream physiological roles. The histone chaperone HIRA was identified as an epigenomic regulator of adipose tissue function: adipose-specific Hira knockout in mice impaired insulin sensitivity and restrained high-fat-diet-induced adipose expansion, and HIRA was required for Adipoq and lipid metabolism gene expression, binding their promoters and enhancers. Acute dTAG-mediated HIRA depletion combined with nascent RNA-Seq and ChIP-Seq showed that HIRA is largely dispensable for enhancer activation and coactivator recruitment, instead promoting transcription by facilitating RNA polymerase II pause release and elongation, apparently independently of H3.3 deposition 42406969Jul. On the physiological side, global adiponectin knockout mice of both sexes were studied under ad libitum feeding versus 30% caloric restriction, a state in which circulating adiponectin normally rises. Knockout did not alter caloric-restriction effects on body mass, composition, or energy expenditure, but unexpectedly lowered fasting and post-challenge blood glucose during restriction without changes in insulin levels or sensitivity — the opposite of adiponectin deficiency under ad libitum or obese conditions — while augmenting caloric-restriction-induced increases in plasma fatty acids in both sexes and impairing systemic triglyceride clearance in males only, with sex- and diet-specific effects in white adipose tissue 42313833Jun.

Receptor- and pathway-level analyses extended adiponectin signaling into liver disease and oncology. In non-alcoholic steatohepatitis, ADIPOR2 (encoding AdipoR2) was found to be upregulated in patient datasets relative to healthy controls with good diagnostic value, and its expression was linked to immune microenvironment composition — notably resting CD4 memory T cells and resting dendritic cells — as well as metabolic dysfunction, supported by regulatory network construction, drug sensitivity analysis, and clinical sample validation 42432956Jul. In colorectal cancer, black phosphorus nanosheets selectively killed Caco-2 cells by apoptosis above 4 μg/mL while normal FHC intestinal cells largely underwent necrosis at higher concentrations; transcriptomic and biochemical work traced this selectivity to disruption of PPARγ/RXRα complex formation, cancer-cell-specific downregulation of the oxidative stress-related gene ADIPOQ together with PPARα, impaired peroxisome proliferation, redox imbalance, DNA damage, and p53 pathway activation 41763508Feb.

Taken together, these studies show adiponectin operating simultaneously as a diagnostic biomarker in autoimmune, neurodegenerative, and cerebrovascular settings, as a transcriptionally regulated node controlling insulin sensitivity and lipid handling, and — through its receptor and its redox-linked gene expression — as a determinant of immune infiltration in steatohepatitis and of nanomaterial-induced cell-type-selective killing in colorectal cancer. Recurring themes include the importance of isoform and context (HMW versus total adiponectin; caloric restriction versus obesity), where classical assumptions about adiponectin's protective role do not hold uniformly 42360686Jun42313833Jun.

What Changes, What Holds

1. Adiponectin now functions more as a context-dependent diagnostic readout than as a uniform disease marker
NEW DIRECTION Plasma and CSF studies extend adiponectin into autoimmune, neurodegenerative, and cerebrovascular assessment, but the main implication is not a new mechanism; it is that total concentration alone may be less informative than isoform pattern or multivariable context. The Alzheimer’s data especially temper the idea that higher adiponectin is straightforwardly disease-linked, because adjustment removes the apparent association while the HMW/total ratio persists 42360686Jun41057170Oct.

2. Adiponectin belongs in broader endocrine panels rather than as an isolated metabolic signal
REINFORCES These comparisons do not overturn the established links to energy homeostasis, lipid handling, and glucose metabolism; they sharpen the point that adiponectin varies with endocrine comorbidity and body composition alongside other adipocytokines. The practical takeaway is that interpretation should be relational, not absolute, especially when thyroid disease, diabetes, and pregnancy-related metabolic remodeling are present 42455070Jul42240794Jun.

3. AdipoQ expression is actively controlled by chromatin machinery, and caloric restriction can uncouple adiponectin from its expected metabolic effects
NEW DIRECTION HIRA adds an upstream transcriptional layer to the Overview’s account of adiponectin biology, showing that adiponectin production is not just a passive adipocyte trait but a regulated output of promoter/enhancer control. More strikingly, the caloric-restriction knockout data complicate the usual assumption that less adiponectin simply means worse glucose control, because the phenotype reverses under restriction. That tension will need mechanistic resolution 42406969Jul42313833Jun.

4. Adiponectin signaling now appears relevant to immune infiltration in steatohepatitis and to redox-linked selectivity in colorectal cancer
NEW DIRECTION ADIPOR2 upregulation in liver disease broadens the receptor story beyond the Overview’s general metabolic framing, suggesting a role in shaping immune microenvironments as well as metabolism. The colorectal cancer work goes further by tying cancer-cell ADIPOQ downregulation to oxidative stress and cell death, which fits the Overview’s cancer context but adds a more specific redox-selective mechanism. These are extensions, not replacements, of the established account 42432956Jul41763508Feb.

5. Adiponectin should be understood as a context-sensitive biomarker and regulator whose direction of effect is not uniform across disease states
REINFORCES The recent studies collectively support the baseline view that adiponectin tracks adipose function, insulin sensitivity, and systemic metabolic state, while also showing that its readout depends on isoform, disease context, and nutritional state. What remains unsettled is whether these context effects reflect biology that is genuinely bidirectional or simply different windows onto the same underlying adipose dysfunction 42360686Jun42313833Jun42432956Jul.

Overview update candidates: adiponectin as a context-dependent diagnostic biomarker; HIRA as an upstream regulator of AdipoQ expression; caloric restriction uncoupling adiponectin deficiency from expected glycemic worsening; ADIPOR2 involvement in steatohepatitis immune microenvironment; ADIPOQ downregulation linked to redox-selective colorectal cancer killing.